Navigation Links
CryoCath Appoints New Chief Financial Officer
Date:2/26/2008

Toronto Stock Exchange Symbol: CYT

http://www.cryocath.com

MONTREAL, Feb. 26 /PRNewswire-FirstCall/ - CryoCath(R) Technologies Inc., the global leader in cryotherapy products to treat cardiac arrhythmias, today announced that Chief Financial Officer, L. Derek Lindsay, will be leaving the Company on April 4, 2008. Effective April 7, 2008, Ginette Gagne will take over the role of Chief Financial Officer at CryoCath. Mr. Lindsay has agreed to stay on in the role of Chief Financial Officer to ensure a smooth transition.

"Since joining CryoCath, Derek has been actively involved in significant change and we thank him for his contributions to the Company's development and wish him well for the future," said Jan Keltjens, President and Chief Executive Officer of CryoCath. "I am very pleased to announce the appointment of Ginette Gagne to the position of Chief Financial Officer at CryoCath. Her extensive experience building and running world-class financial organizations, combined with her hands-on experience in the global medical device business, will support CryoCath in achieving our ambitious growth strategy."

Over the past 19 years, Ginette has developed an impressive career track record through leadership positions in various corporations with progressive senior roles and responsibilities. She joins CryoCath from Boston Scientific Corporation, where she most recently served as Vice President Finance of Europe. In this capacity, she was responsible for managing a team of more than 150 people in 30 countries and played a key role in transitioning their business from a highly centralized model to a country focused model. Before this assignment she was the Vice President, Finance of Boston Scientific Inter Continental. Prior to her eight years with Boston Scientific, Ginette held financial leadership roles at Fisher Scientific International, Fisher France OSI S.A. and Fisher Scientific Canada. She began her career with Northern Telecom Ltd.

About CryoCath

CryoCath - http://www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.

This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at http://www.sedar.com under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.


'/>"/>
SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CryoCath Technologies notice of annual meeting
2. CryoCath Announces Fiscal 2008 First Quarter Results
3. CryoCath Provides Update on Patent Infringement Lawsuit
4. CryoCath to Hold First Quarter 2008 Conference Call and Webcast
5. CryoCath intends to contest patent infringement claim by CryoCor, Inc.
6. CryoCath announces 2007 fourth quarter and fiscal year end financial results
7. CryoCath to present at Piper Jaffray and BMO Healthcare conferences
8. CryoCath to present at CIBC Healthcare Conference
9. CryoCath files patent infringement lawsuit
10. Ceremed Appoints Vice President for Sales and Business Development
11. ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their approach ... patient is doing more than filling out a survey; in many cases health professionals ... emphasis in health care and research on the importance of active engagement with patients ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
Breaking Medicine Technology: